← Leaderboards
Melissa H. Bloodworth
Vanderbilt University
$152,155
Attributed
$152,155
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $31.4K · FY2015–19$50K$37.5K$25K$12.5K$0
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$152,155 · 1
By mechanism
F30$152,155 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Tina V Hartert$33,847,643
- John V Williams$14,790,794
- Raymond Nelson Dubois$22,706,669
- Ivan M Robbins$2,964,589
- Michael Allan Holinstat$11,456,655
Others in their field
Top investigators on “Fda Approved”
- Thomas Macvittie · University Of Maryland Baltimore$64,108,499
- David H Walker · University Of Texas Medical Br Galveston$61,066,312
- Polly Chang · Sri International$60,528,575
- Henry F Chambers · Duke University$48,458,380
- Robert H Vonderheide · University Of Pennsylvania$48,412,540
- Susan Abushakra · Alzheon, Inc.$47,690,244
Research focus
Fda ApprovedHospitalizationActivities Of Daily LivingEpoprostenolGenetic PolymorphismHistologyArachidonic AcidsAirway EpitheliumAntibodiesBronchiolitisGenesFunctional DisorderCellsChildhood AsthmaChimeric ProteinsClinical EffectivenessClinically SignificantAttenuatedBody Weight DecreasedCytokineEnvironmental Air FlowEnzymesAirway ObstructionHypertension Control
Grant awards (5)
Exogenous PGI2 protection against RSV-induced illness$30,171
F30 · FY2019 · AI · contact PI
Exogenous PGI2 protection against RSV-induced illness$31,376
F30 · FY2018 · AI · contact PI
Exogenous PGI2 protection against RSV-induced illness$30,778
F30 · FY2017 · AI · contact PI
Exogenous PGI2 protection against RSV-induced illness$30,197
F30 · FY2016 · AI · contact PI
Exogenous PGI2 protection against RSV-induced illness$29,633
F30 · FY2015 · AI · contact PI